Accelerate Diagnostics Inc (AXDX) Live Share Price, Invest From India

Accelerate Diagnostics Inc Stock Performance

as on May 15, 2025 at 6:58 am IST

$0.04
Day's Price Range
$0.04
$0.04
52 Week's Low
52 Week's High
$0.07
52-Week Price Range
$0.64
$0.04
-82.00%
Downside
1489.50%
Upside

Accelerate Diagnostics Inc share price movements today

Previous Close: $0.09
Open: $0.04
Volume: 17.6K
Day's Low - High: $0.04 - $0.04
52 Week Low - High: $0.07 - $0.64

Accelerate Diagnostics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Accelerate Diagnostics Inc Stock Fundamentals & Key Indicators

Check Accelerate Diagnostics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Accelerate Diagnostics Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Accelerate Diagnostics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Accelerate Diagnostics Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Accelerate Diagnostics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Accelerate Diagnostics Inc. Average target price of $1.5

Accelerate Diagnostics Inc Share Price Target

Get share price movements and forecasts by analysts on Accelerate Diagnostics Inc.

What analysts predicted

97.33%UPSIDE

Target Price

$1.5

Current Price

$0.04

Analyzed by

7 Analysts

Target

$1.50

Accelerate Diagnostics Inc target price $1.5, a slight upside of 97.33% compared to current price of $0.04. According to 7 analysts rating.

Accelerate Diagnostics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	2	2	2	3	3	2	2	2	2	2
Gross Profit	0	1	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-14	-17	-25	0	-13	-14	-11	-14	-9	-9
Net Profit Margin	-497.98%	-638.19%	-889.42%	27.58%	-433.33%	-487.16%	-388.08%	-492.07%	-340.52%	-340.52%

Accelerate Diagnostics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	4	5	9	11	11	12	12	11
Gross Profit	0	0	3	2	4	4	0	3	2	2
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-45	-66	-62	-88	-84	-78	-77	-62	-61	-50
Net Profit Margin	-30951.02%	-26981.30%	-1505.43%	-1557.78%	-906.80%	-700.47%	-659.50%	-490.06%	-510.97%	-427.81%

Global Institutional Holdings in Accelerate Diagnostics Inc

Funds	Holdings
Armistice Capital, LLC	8.24%
Hovey Youngman Associates Inc	3.38%
Vanguard Group Inc	1.9%
Geode Capital Management, LLC	0.54%
Spears Abacus Advisors LLC	0.45%

See all

About Accelerate Diagnostics Inc

Accelerate Diagnostics, Inc. is in vitro diagnostics company engaged in providing solutions for the global challenges of antibiotic resistance and sepsis. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.

Organisation	Accelerate Diagnostics Inc
E-voting on shares	Click here to vote

FAQs

What is Accelerate Diagnostics Inc share price today?

Accelerate Diagnostics Inc share price today is $0.04 as on May 15, 2025 at 1:28 am IST at the close of the market. Accelerate Diagnostics Inc share today touched a day high of $0.04 and a low of $0.04.

What is the 52 week high and 52 week low for Accelerate Diagnostics Inc share?

Accelerate Diagnostics Inc share touched a 52 week high of $0.64 on April 15, 2025 and a 52 week low of $0.07 on May 13, 2025. Accelerate Diagnostics Inc stock price today i.e. May 15, 2025 at 1:28 am IST is closed at $0.04,which is 93.71% down from its 52 week high and -45.05% up from its 52 week low.

How to invest in Accelerate Diagnostics Inc Stock (AXDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Accelerate Diagnostics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Accelerate Diagnostics Inc Shares that will get you 37.5000 shares as per Accelerate Diagnostics Inc share price of $0.04 per share as on May 15, 2025 at 1:28 am IST.

What is the minimum amount required to buy Accelerate Diagnostics Inc Stock (AXDX) from India?

Indian investors can start investing in Accelerate Diagnostics Inc (AXDX) shares with as little as ₹93.048 or $1 (as of April 12, 2026 at 10:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹930.48 in Accelerate Diagnostics Inc stock (as per the Rupee-Dollar exchange rate as on April 12, 2026 at 10:41 pm IST). Based on Accelerate Diagnostics Inc share’s latest price of $0.04 as on May 15, 2025 at 1:28 am IST, you will get 250.0000 shares of Accelerate Diagnostics Inc. Learn more about fractional shares .